不同光照制度对绍兴鸭和高邮鸭生长与相关激素及其基因表达的影响

取33日龄高邮鸭和绍兴鸭公鸭各32只，每品种分为两组，分别给以20h和6h光照，试验期14d。试验前后称重。Nothern杂交法测定垂体GH mRNA和下丘脑SS mRNA表达水平，放免法测定血清中生长激素（GH）、胰岛素生长因子－1（IGF－1）、甲状腺激素（T3、T4）水平。结果表明：高邮鸭20h光照时增重、GH及T4水平显著低于6h光照（P＜0．01）；而绍兴鸭的增重变化则与高邮鸭相比（P＜0．01），血浆GH水平变化与高邮鸭相同，T4水平无显著变化。光照制度的改变未引起两品种鸭IGF－1、T3水平的显著变化。垂体GH mRNA表达水平的变化与增重变化相反。提示光照直接影响鸭生长轴基因的表达以及激素水平，从而显著影响生长速率，但这种影响在不同品种可有完全不同的表现。     

Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis)

The pharmacokinetics and dosage regimen of cefotaxime following its single subcutaneous administration (10 mg/kg) were investigated in buffalo calves. Plasma and urine samples were collected over 10 and 24 h post administration, respectively. Cefotaxime in plasma and urine was estimated by microbiological assay technique using E. coli as test organism. The pharmacokinetic profiles fitted one-compartment open model. The peak plasma levels of cefotaxime were 6.48 ± 0.52 µg/ml at 30 min and the drug was detected upto 10 h. The absorption half-life and elimination half-life were 0.173 ± 0.033 h and 1.77 ± 0.02 h, respectively. The apparent volume of distribution and total body clearance were 1.17 ± 0.10 l/kg and 0.45 ± 0.03 l/kg/h, respectively. The urinary excretion of cefotaxime in 24 h, was 5.36 ± 1.19 percent of total administrated dose. A satisfactory subcutaneous dosage regimen for cefotaxime in buffalo calves would be 13 mg/kg repeated at 12 h intervals.     

Effects of step-up and step-down phytase regimens on performance and processing yields of male broilers from 1 to 35 d of age

An experiment was conducted to evaluate increasing or decreasing concentrations of dietary phytase on growth performance and processing yields of male broilers from 1 to 35 d of age. Treatments consisted of a positive control, a negative control (NC; less 0.14% Ca, 0.13% nonphytate P, and 0.03% Na), and 6 additional treatments based on the NC supplemented with phytase. Treatments 3 through 5 consisted of the NC diet supplemented with 500 phytase units (FTU)/kg of phytase in the starter phase that was either continued throughout the remainder of the study (treatment 3) or increased to 1,500 FTU/kg beginning in the finisher (treatment 4) or grower (treatment 5) phases. Treatment 6 had 1,500 FTU/kg of phytase throughout the study. Treatments 7 and 8 had 1,500 FTU/kg in the starter and decreased to 500 FTU/kg in the finisher or grower phases, respectively. At 35 d of age, broilers fed diets containing 1,500 FTU/kg of phytase had increased BW gain compared with birds fed diets formulated to contain 500 FTU/kg of phytase. Increasing phytase concentration between the starter and grower phases or decreasing phytase concentration between the grower and finisher phases negatively affected FCR from 1 to 35 d of age. Phytase supplementation did not affect weight and yield of carcass characteristics. Therefore, dietary phytase concentration should not be varied throughout production for optimum growth performance.     

Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours

Oncolytic virotherapy is a novel treatment involving replication‐competent virus in the elimination of cancer. We have previously reported the oncolytic effects of reovirus in various canine cancer cell lines. This study aims to establish the safety profile of reovirus in dogs with spontaneously occurring tumours and to determine a recommended dosing regimen. Nineteen dogs with various tumours, mostly of advanced stages, were treated with reovirus, ranging from 1.0 × 10⁸ to 5.0 × 10⁹ TCID₅₀ given as intratumour injection (IT) or intravenous infusion (IV) daily for up to 5 consecutive days in 1 or multiple treatment cycles. Adverse events (AEs) were graded according to the Veterinary Cooperative Oncology Group‐ Common Terminology Criteria for Adverse Events (VCOG‐CTCAE) v1.1 guidelines. Viral shedding, neutralizing anti‐reovirus antibody (NARA) production and immunohistochemical (IHC) detection of reovirus protein in the tumours were also assessed. AE was not observed in most dogs and events were limited to Grade I or II fever, vomiting, diarrhoea and inflammation of the injected tumour. No infectious virus was shed and all dogs had elevated NARA levels post‐treatment. Although IHC results were only available in 6 dogs, 4 were detected positive for reovirus protein. In conclusion, reovirus is well‐tolerated and can be given safely to tumour‐bearing dogs according to the dosing regimen used in this study without significant concerns of viral shedding. Reovirus is also potentially effective in various types of canine tumours.     

Use of group records of feed intake to select for feed efficiency in rabbit

Models for genetic evaluation of feed efficiency ( FE ) for animals housed in groups when they are either fed ad libitum ( F ) or on restricted ( R ) feeding were implemented. Definitions of FE on F included group records of feed intake () and individual records of growth rate ( G_F ) and metabolic weight ( M_F ). Growth rate ( G_R ) as FE measurement on R was used. Data corresponded to 5,336 kits from a rabbit sire line, from 1,255 litters in 14 batches and 667 cages. A five‐trait mixed model (also with metabolic weight on R, M_R ) was implemented including, for each trait, the systematic effects of batch, body weight at weaning, parity order and litter size; and the random effects of litter, additive genetic and individual. A Bayesian analysis was performed. Conditional traits such as and were obtained from elements of additive genetics ( and ) or phenotypic ( and ) (co)variance matrices. In the first case, heritabilities were low (0.07 and 0.06 for and , respectively) but null genetic correlation between the conditional and conditioning traits is guaranteed. In the second case, heritabilities were higher (0.22 and 0.16 for and , respectively) but the genetic correlation between and was moderate (0.58). Heritability of G_R was low (0.08). This trait was negatively correlated with and of animals on F, which indicate a different genetic background. The correlation between G_R and G_F was also low to moderate (0.48) and the additive variance of G_F was almost four times that of G_R, suggesting the presence of a substantial genotype by feeding regimen interaction.     

复方氟康唑软膏临床药效试验

为研究复方氟康唑软膏对犬耳道真菌、细菌感染的治疗效果,发犬为试验用动物,采用人工感染和自然感染犬,以耳肤灵为对照,进行42d的临床药效研究。人工感染临床试验结果显示,复方氟康唑软膏和耳肤灵对犬耳道感染均有较好的治疗效果,两者无显著性差异(P>0.05);复方氟康唑软膏推荐剂量组和加倍剂量组对耳道感染的治愈率+显效率均为90%,且与空白对照组相比,差异极显著(P<0.01)。自然感染临床药效试验数据表明,耳肤灵和复方氟康唑软膏对真菌、细菌引起的耳道感染的治愈率+显效率均大于90%,且差异不显著(P>0.05),再次验证了复方氟康唑软膏推荐剂量对犬耳道细菌、真菌感染的治疗效果。表明复方氟康唑软膏推荐剂量(0.5mL/耳,1次/d,连续给药4周)可用于犬耳道细菌、真菌感染的治疗,治疗效果较好,可以在临床中推广使用。     

抗微生物药物PK-PD研究在优化兽药给药方案中的应用

PK-PD模型可用于优化兽药给药方案,制订合理的给药间隔和剂量,在减少细菌耐药性方面有重要意义.本文综述了β-内酰胺类、氨基糖苷类、氟喹诺酮类、大环内酯类等抗微生物药物的PK-PD研究现状,以期为兽药厂家在药物开发、设计合理的剂型与给药方案方面提供依据.     

Effects of feeding regimen of dietary Aspergillus oryzae on the growth performance,intestinal morphometry and blood profile of Nile tilapia (Oreochromis niloticus)

The current study was conducted to evaluate the feeding regimen of Aspergillus oryzae (ASP) on the growth, intestinal histomorphology and blood profile of Nile tilapia (Oreochromis niloticus). Four different ASP‐feeding regimens were evaluated, including feeding the basal diet continuously (control), feeding ASP (1 g/kg) continuously (ASPC), feeding ASP for 1 day and the next day without (ASPF1) or feeding ASP for 1 day and the two next days without (ASPF2). After 60 days, the final weight, weight gain, SGR, feed intake, protein efficiency, protein gain, body protein content, haematocrit, haemoglobin, and RBC and WBC values were increased significantly (p < 0.05) with lower glutamic‐pyruvate transaminase in ASPC group compared to the control without no difference (p > 0.05) with ASPF1‐feeding regimen. Interestingly, glutamyl oxaloacetic transaminase was significantly reduced in all feeding regimens compared to the control (p < 0.05). Protease, lipase and villi length were significantly (p < 0.05) improved in all feeding regimens compared to the control, while amylase activity increased only in ASPC group. Thus, the obtained results indicated that all ASP‐feeding regimens resulted in quite similar outcomes with respect to growth, digestive enzyme activity and intestinal histomorphology.     

Compensatory growth and digestive enzyme activity of Litopenaeus vannamei submitted to feeding restriction in a biofloc system

Feeding restriction is a strategy in shrimp farming management that may promote compensatory growth after feeding is re‐established. This study aims to evaluate the effects of two feeding restriction regimens on the compensatory growth and digestive enzymes activity of Litopenaeus vannamei reared in biofloc system. Juvenile shrimp (0.46 ± 0.18 g) were stocked (320 individuals/m³) in 310 L tanks. The experiment comprised two phases: (a) Feeding Restriction (30 days) when shrimp were submitted to three feeding regimes, Control (fed daily), R1F1 (repetitively fasted one day and fed one day) and R2F1 (repetitively fasted 2 days and fed 1 day); and (b) Refeeding (28 days) when shrimp were fed daily. In the restriction phase, shrimp growth and digestive enzyme activities were reduced in R2F1 and R1F1. However, during the refeeding phase, enzyme activities and feed conversion improve significantly in R2F1 and R1F1. Control group attained higher final weight, but its final biomass was similar to R1F1. Litopenaeus vannamei exhibited partial compensatory growth, probably due to improved feed conversion efficiency driven by increased enzyme activity. It is possible to reduce feeding by 50% (R1F1) in biofloc systems for 28 days, without compromising the biomass produced at the end of a 30‐day refeeding period.     

Experimental infections with Cooperia oncophora in calves. A study with two different larval dose levels and dosing regimens.

The effect of different larval dose level and dosing regimens on the course of Cooperia oncophora infection in calves was studied. Four groups each of 4 calves were experimentally infected either with 50,000 or 200,000 C. oncophora larvae (L3) given either as single infections or as daily trickle infections. An additional group of calves remained as uninfected controls. The animals were necropsied on week 4 after infection. Mild to moderate clinical signs of parasitic gastroenteritis developed among calves given high doses of larvae, but liveweight gains were not significantly different from those of the uninfected controls. Serum pepsinogen levels of dosed animals were within normal ranges but rose slightly, and on day 14 p.i. they differed significantly from those of the controls. On that occasion, the levels of serum pepsinogen in the trickle infected groups significantly exhibited the levels of the single infected groups. Hypoalbuminaemia was not a feature on any occasion. The various groups did not differ significantly with regard to total worm counts and adult worm counts, but the groups receiving high larval dose harboured significantly more fourth stage larvae than the group receiving low doses of larvae, both in terms of absolute counts and in terms of percentages of total worm burdens. Within the same dose level, there was a tendency of a more even distribution of worms along the small intestine when the infections was given as a single infection compared with a trickle infection. The results indicate that C. oncophora larval dose and dosing regimens may influence the pathogenic effects and to some extent the distribution of the parasite in the small intestine.